metformin has been researched along with anagliptin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baik, SH; Choi, SH; Chung, CH; Jin, SM; Kim, DM; Lee, HW; Lee, IK; Lee, MK; Min, KW; Park, IB; Park, JY; Park, KS; Park, SW; Song, KH; Yoon, KH | 1 |
| Goto, M; Hariya, N; Mochizuki, K; Osonoi, T; Saito, M | 1 |
| Hamajima, H; Inoue, E; Mieno, E; Miyachi, A; Nagai, Y; Nakagawa, T; Takahashi, M; Tanaka, Y; Yamamoto, Y | 1 |
| Ahn, KJ; Choi, KM; Chung, CH; Jang, HC; Kim, DM; Kim, SG; Kwon, SK; Lee, SH; Lee, YH; Park, HK; Park, KS; Son, HS; Song, KH; Won, KC; Yu, JM | 1 |
4 trial(s) available for metformin and anagliptin
| Article | Year |
|---|---|
Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Proinsulin; Pyrimidines; Sitagliptin Phosphate | 2015 |
Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Leptin; Male; Metformin; Middle Aged; Pyrimidines; Treatment Outcome | 2016 |
Effects of anagliptin on plasma glucagon levels and gastric emptying in patients with type 2 diabetes: An exploratory randomized controlled trial versus metformin.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Glucagon; Humans; Hypoglycemic Agents; Male; Mass Spectrometry; Metformin; Middle Aged; Prospective Studies; Pyrimidines; Young Adult | 2019 |
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Protease Inhibitors; Sitagliptin Phosphate; Treatment Outcome | 2023 |